Skip to main content

Day: February 28, 2022

PDC Energy Announces $1.3 Billion Core Wattenberg Acquisition, Establishes Enhanced Return of Capital Framework, Provides 2021 Results and 2022 Guidance

Acquisition Adds Significant Scale to Core Wattenberg Position, is Accretive to Key Financial and Operating Metrics, Maintains Strong Balance Sheet Increases Quarterly Base Dividend More Than 100% to $0.25 per Share with Expectations to Further Increase to $0.35 per Share Upon Acquisition Closing Commits to Returning a Minimum of 60% of Annual Post-Dividend FCF to Shareholders via Systematic Share Repurchases and Special Dividend, if needed Increases Board-Authorized Share Repurchase Program to $1.25 Billion PDC to Host Investor Call Today at 11:00 a.m. ET / 9:00 a.m. MT DENVER, Feb. 28, 2022 (GLOBE NEWSWIRE) — PDC Energy, Inc. (“PDC” or the “Company”) (Nasdaq:PDCE) today announced it has entered into a definitive purchase agreement with Great Western Petroleum, LLC (“Great Western”) and certain sellers under which PDC will acquire...

Continue reading

Party City Reports Fourth Quarter and Full Year 2021 Results

Total Net Sales Increased 7.7% in Fourth Quarter and 17.3% in 2021 versus prior year Fourth Quarter Comparable Sales Increased 17.8% versus prior year driven by strength in core categories Fourth Quarter GAAP Net Loss of $19.5 million; Adjusted Net Income of $46.7 million Fourth Quarter Adjusted EBITDA Increased 36.1% to $105.2 million ELMSFORD, N.Y., Feb. 28, 2022 (GLOBE NEWSWIRE) — Party City Holdco Inc. (the “Company” or “PRTY”; NYSE:PRTY) today announced financial results for the quarter and full year ended December 31, 2021. Brad Weston, Chief Executive Officer of Party City, stated, “We are pleased with our fourth quarter and full year results that were in-line with our expectations as we closed out another successful year. To that end, 2021 was an important year of transformation for the Company as we advanced the fundamental...

Continue reading

Healthcare Realty and Healthcare Trust of America Enter Into $18 Billion Strategic Combination

Creates Preeminent, High Quality MOB REITLed by Existing Healthcare Realty Executive Team and ChairmanHealthcare Realty Name and Ticker Symbol (NYSE: HR)Expected to be Accretive with Material Cost Synergies and Operational Upside Conference Call to be held at 8:30 AM E.T. NASHVILLE, Tenn. and SCOTTSDALE, Ariz., Feb. 28, 2022 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE:HR) (“Healthcare Realty” or “HR”) and Healthcare Trust of America, Inc. (NYSE: HTA) (“Healthcare Trust of America” or “HTA”) today announced that they have agreed to enter into a strategic business combination. HTA shareholders will receive a total implied value of $35.08 per share comprised of a special cash dividend of $4.82 per share and a transaction exchange ratio of 1:1 based on HR’s unaffected price of $30.26 on February 24, 2022. This transaction...

Continue reading

Brown & Brown, Inc. enters into agreement to acquire Orchid Underwriters Agency and CrossCover Insurance Services

DAYTONA BEACH, Fla., Feb. 28, 2022 (GLOBE NEWSWIRE) — J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. (NYSE:BRO), and the ownership team of Orchid Underwriters Agency (“Orchid”) and CrossCover Insurance Services (“CrossCover”), today announced that Brown & Brown, Inc. (Brown & Brown) has entered into an agreement to acquire Orchid and CrossCover. The transaction is expected to close before April 2022, subject to certain closing conditions. Established in 1998, Orchid has grown to become a leading program administrator by representing best-in-class insurance and reinsurance providers and partnering with qualified independent retail brokers and select wholesale brokers. Orchid delivers proprietary and customized insurance solutions for homeowners in coastal zones and for high net worth customers....

Continue reading

Apria Announces Financial Results for Fourth Quarter and Full Year 2021

INDIANAPOLIS, Feb. 28, 2022 (GLOBE NEWSWIRE) — Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR), a leading provider of integrated home healthcare equipment and related services in the United States, announced today financial results for the fourth quarter and full year ended December 31, 2021. As previously announced, the Company will not be hosting a conference call to discuss its financial results. “We reported solid fourth quarter financial results and 2021 was a good year for Apria. Our team did an excellent job operating and executing at a high level while navigating the challenges from the COVID-19 pandemic, as well as a major product recall and supply chain constraints. Fourth quarter revenue and Adjusted EBITDA were at the high end of our guidance ranges, while Adjusted EBITDA less Patient Equipment Capex was in-line...

Continue reading

Beam Therapeutics Reports Pipeline and Business Highlights, Planned 2022 Milestones and Fourth Quarter and Full Year 2021 Financial Results

Research Collaboration with Pfizer Underway, with Upfront and Potential Milestone Payments of Up to $1.35 Billion Executing First Wave of Long-term Strategy for Sickle Cell Disease with Planned Initiation of BEAM-101 Clinical Trial and IND Submission for BEAM-102 in the Second Half of 2022 Strong Cash Position of $1.2 Billion, Including Pfizer Upfront, to Support Robust Set of Milestones Across Ex Vivo and In Vivo Base Editing Programs Anticipated in 2022 and Beyond CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced pipeline and business highlights, outlined key 2022 anticipated milestones and reported fourth quarter and full year 2021 financial results. “Throughout 2021, we made important...

Continue reading

Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Clinical Update

Conference Call and Webcast at 8:00 am Eastern Time THE WOODLANDS, Texas, Feb. 28, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today reported financial results for the three months and full-year ended December 31, 2021 and provided an update on key milestones. “We remain focused on advancing sotagliflozin for the millions of people suffering from heart failure and living with type 2 diabetes on a daily basis. We announced today that we voluntarily withdrew the sotagliflozin NDA to correct a technical issue that we recently identified, and we plan to promptly resubmit early in the second quarter of 2022,” said Lonnel Coats, Lexicon’s chief executive officer. “In addition, we are looking forward to completing and announcing top-line results in the coming months from our two proof-of-concept Phase 2 studies...

Continue reading

Solstice Appoints Lisa Doddridge to its Board of Directors

Forms Board Level ESG Committee VANCOUVER, British Columbia, Feb. 28, 2022 (GLOBE NEWSWIRE) — Solstice Gold Corp. (TSXV: SGC) (“Solstice”, “we”, “our” or the “Company”) is pleased to announce that it has appointed Lisa Doddridge to its board of directors. Ms. Doddridge was most recently Director, Investor Relations at First Quantum Minerals where she led the team to several investor relations awards in 2020 and helped establish the company as one of the Top 100 in IR in Canada. She has been a dedicated mining executive focused on corporate communications with solid capital markets knowledge and extensive experience engaging with the analyst community and institutional investors globally over a long track record of success in the last 20 years. She has been responsible for the formulation and successful execution of investor relations...

Continue reading

Everything Blockchain Accelerates Corporate Rebranding

Jacksonville, Florida, Feb. 28, 2022 (GLOBE NEWSWIRE) — Everything Blockchain, Inc. (OTCMKTS: OBTX), an advanced platform architect, development and services company and software foundry, specializing in blockchain technologies, decentralized processing, and zero trust applications, is undergoing a corporate rebranding as the company continues to grow its national and international footprint. The company has recently completed several strategic acquisitions as it expands its blockchain, development, engineering and decentralized processing services. In addition, the Company is expected to have its operations expanded into Saudi Arabia and the European theatre. The rebranding will encompass the company’s website, marketing materials, logos and more. “This process goes beyond design to include our overall vision and reach, and a...

Continue reading

Dentsply Sirona Reports Fourth Quarter and Full Year 2021 Results

FY21 net sales increased 27.2% to $4,251 million, organic sales increased 24.6% FY21 operating income of $622 million, adjusted operating income increased 62.3% to $871 million FY21 EPS of $1.91, adjusted EPS increased 60.3% to $2.87 FY21 operating cash flow increased to $657 million vs $635 million in FY20 Q4 net sales increased 0.6% to $1,088 million, organic sales increased 1.8% Q4 operating income of $154 million, adjusted operating income decreased 13.7% to $217 million FY22 outlook: organic sales growth 4% to 5%, adjusted EPS range of $3.05 to $3.25CHARLOTTE, N.C., Feb. 28, 2022 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced its financial results for the fourth quarter and full year 2021. Full year 2021 net sales of $4,251 million increased 27.2%,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.